J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrowOA All Versions of this Article:
jmm.0.011122-0v1
58/8/977    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Oyston, P. C. F.
Right arrow Articles by Clark, G. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyston, P. C. F.
Right arrow Articles by Clark, G. C.
Agricola
Right arrow Articles by Oyston, P. C. F.
Right arrow Articles by Clark, G. C.
J Med Microbiol 58 (2009), 977-987; DOI: 10.1099/jmm.0.011122-0
© 2009 Society for General Microbiology
ISSN 0022-2615

Novel peptide therapeutics for treatment of infections

P. C. F. Oyston, M. A. Fox, S. J. Richards and G. C. Clark

Microbiology, Dstl Porton Down, Salisbury, Wiltshire SP4 0JQ, UK

Correspondence
P. C. F. Oyston
pcoyston{at}dstl.gov.uk


As antibiotic resistance increases worldwide, there is an increasing pressure to develop novel classes of antimicrobial compounds to fight infectious disease. Peptide therapeutics represent a novel class of therapeutic agents. Some, such as cationic antimicrobial peptides and peptidoglycan recognition proteins, have been identified from studies of innate immune effector mechanisms, while others are completely novel compounds generated in biological systems. Currently, only selected cationic antimicrobial peptides have been licensed, and only for topical applications. However, research using new approaches to identify novel antimicrobial peptide therapeutics, and new approaches to delivery and improving stability, will result in an increased range of peptide therapeutics available in the clinic for broader applications.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.